Cronos (CRON) EBIT Margin (2018 - 2026)

Cronos (CRON) recorded quarterly EBIT Margin of 4.05% in Q1 2026, up 93.72% quarter-over-quarter from 64.57% in Q4 2025, and up 566.0% on a YoY basis from 0.61% in Q1 2025.

Cronos (CRON) EBIT Margin (2018 - 2026) Analysis & Trends

Cronos' EBIT Margin history runs 9 years deep, the most recent figure standing at 4.05% for Q1 2026.

  • In Q1 2026, EBIT Margin rose 566.0% year-over-year to 4.05%; the TTM figure through Mar 2026 stood at 10.11% (up 3443.0% YoY), while the FY2025 annual figure was 11.87%, up 5320.0% from the prior year.
  • EBIT Margin was 4.05% for Q1 2026 at Cronos, up from 64.57% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 1.03% in Q3 2025 to a low of 122.59% in Q1 2022.
  • Historically, EBIT Margin has averaged 59.1% across 5 years, with a median of 64.21% in 2023.
  • Biggest YoY gain for EBIT Margin was 180359 bps in 2022; the steepest drop was 75875 bps in 2022.
  • A 5-year view of EBIT Margin shows it stood at 93.03% in 2022, then soared by 59 bps to 38.0% in 2023, then increased by 1 bps to 37.51% in 2024, then tumbled by 72 bps to 64.57% in 2025, then soared by 94 bps to 4.05% in 2026.
  • The last three EBIT Margin figures came in at 4.05% (Q1 2026), 64.57% (Q4 2025), and 1.03% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 16.37%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 36.83%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 20.77%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 23.74%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 22.39%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -122.23%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 21.55%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -12.88%
10 Cronos 1.06 Bn 284.85 Mn 19.15 Mn -4.05%

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.05%
Dec 31, 2025 -64.57%
Sep 30, 2025 -1.03%
Jun 30, 2025 -12.03%
Mar 31, 2025 -9.72%
Dec 31, 2024 -37.51%
Sep 30, 2024 -98.22%
Jun 30, 2024 -40.23%
Mar 31, 2024 -63.07%
Dec 31, 2023 -38.00%
Sep 30, 2023 -64.21%
Jun 30, 2023 -79.93%
Mar 31, 2023 -78.21%
Dec 31, 2022 -93.03%
Sep 30, 2022 -104.85%
Jun 30, 2022 -93.38%
Mar 31, 2022 -122.59%
Dec 31, 2021 665.72%
Sep 30, 2021 -229.42%
Jun 30, 2021 -1,896.97%